You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Floor Sensors for Occupancy Counting in Commercial Buildings
SBC: SCANALYTICS, INC. Topic: DEFOA0001738The SENSOR FOA clearly identifies a need for people counting in commercial spaces to efficiently allocate HVAC energy, potentially saving 30% in annual energy costs. Scanalytics proposes a materially different, categorically superior floor sensing technology coupled with a device-agnostic platform and real-time processing algorithms to accurately measure occupancy within a space a space such as a ...
SBIR Phase II 2018 Department of EnergyARPA-E -
Parameter Development for the Scaled Manufacturing of Mycelium Bound Panels for Commercial Interior Products
SBC: Ecovative Design Llc Topic: 16NCER6AEcovative Design uses grown mycelium structures to bind agricultural and wood byproducts into inherently nontoxic_x000D_ products containing no added urea formaldehyde or flame-retardant chemicals. This research program focuses_x000D_ on maturing mycelium technology for use in the production of large scale board products, from low density (LD) particle board to acoustic panels and thermal insulati ...
SBIR Phase II 2018 Environmental Protection Agency -
An Enhanced Contact Plasma Reactor: A Competitive Remediation Technology for Per- and Perfluoroalkyl Substance (PFAS) Contaminated Water
SBC: DMAX PLASMA, INC. Topic: 17NCER1APerfluoroalkyl substances (PFASs) have received considerable attention due to their toxicity, ubiquitous presence and recalcitrance. Manufacture and disposal of PFAS-containing products has resulted in PFAS contamination of numerous water supplies. Recent reports indicate the Air Force alone is expecting to spend > $2.25 billion for cleanup for PFAS-contaminated sites. Thus, there is a huge market ...
SBIR Phase I 2018 Environmental Protection Agency -
Green Process for Plastic Chrome
SBC: VERGASON TECHNOLOGY INC Topic: 17NCER5BThis green approach to manufacturing plastic with decorative chrome will eliminate health and environmental hazards from the chrome electroplating process. The US and global market for decorative chrome on plastic is 12 million m2/year and 84 million m2/year respectively, with 80% in automobile trim, 10% in appliances and 10% in sanitary fixtures. Without a viable commercial alternative, US provid ...
SBIR Phase I 2018 Environmental Protection Agency -
Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein-protein interaction
SBC: ANAGIN Topic: 103Abstract This application, “Development of novel small molecule analgesics modulating the nNOS-NOS1AP protein- protein interaction,” addresses the critical need for more effective medications to treat chronic neuropathic pain affecting ~116 million people in the United States. Current pain medications such as NSAIDS, steroids, opiates and gabapentin analogs have documented and often severe sid ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Caring for the Caregiver: A Theory-Driven Mobile Intervention to Promote Caregiver Well-Being
SBC: Pro-Change Behavior Systems, Inc. Topic: NIAOvermillion Americans are currently providing unpaid care to a family memberrelativeor friend with Alzheimer s disease or related dementiaWhile caregiving can be a positive experience that brings meaning and an increased sense of purposeit can also take a tollNearlyof Alzheimer s and dementia caregivers rate their emotional distress as high or very highand as many assuffer from depressionCaregiver ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Enhanced Treatment Management of Opioid-Dependence in an Office-Based Setting
SBC: MedicaSafe Inc Topic: NIDAPROJECT SUMMARY ABSTRACT Opioid use disorder is the leading cause of accidental death in the USwith overlethal drug overdoses inSAMHSA estimates thatmillion Americans misuse prescription opioids for non medical purposes annuallyPublic health officials and policymakers have acknowledged the urgent need for innovative approaches to the treatment of those with opioid use disorderin spite of thisthe a ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Automated Assessment of Leptomeningeal Collaterals on CT Angiograms
SBC: KITWARE INC Topic: 108AbstractThe primary goal of this study is to develop an automated scoring system of leptomeningeal collaterals based on CT angiographyCTAas a quantitative assessment of acute ischemic strokeLeptomeningeal collaterals provide an alternate path of blood flow in the setting of a proximal vessel occlusionThe presence and effectiveness of leptomeningeal collateralsi ecollateral statusvaries significant ...
STTR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Tau oligomer platform validation using lead series candidate in htau mice
SBC: OLIGOMERIX INC Topic: NIATITLETau oligomer platform validation using lead series candidate in htau mice PROJECT SUMMARYSBIR Funding OpportunityAdvancing Research on Alzheimerandapos s DiseaseADand Alzheimerandapos s Disease Related DementiasADRDRRPASThe long term goal of this program is to develop a disease modifyingsmall molecule drug for Alzheimer s diseaseADand related tauopathiesThere is a critical unmet need for a di ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Optimization of small molecule SERCA2b activators to inhibit neuron loss in Alzheimer's disease
SBC: NEURODON, LLC Topic: NIAAlzheimer s diseaseADis an immense national public health burdenIt is theth leading cause of death in the US with overmillion Americans sufferingand costs of over $billion in health care and related expensesThis patient population is expected to almost triple over the nextyearsDespite this urgent needthere are currently no disease modifying agents approvedNeuron loss is the only physiological phen ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health